Fulcrum Therapeutics Inc (FULC)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Fulcrum Therapeutics Inc chart...

About the Company

what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng

Exchange

NASDAQ

Website

fulcrumtx.com

$17M

Total Revenue

111

Employees

$703M

Market Capitalization

-6.89

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $FULC News

Fulcrum Therapeutics appoints Patrick Horn as permanent Chief Medical Officer

18h ago, source: Seeking Alpha on MSN

Fulcrum Therapeutics (NASDAQ:FULC) announces the appointment of Patrick Horn as chief medical officer, effective immediately. The interim Chief Medical Officer, Iain Fraser, will continue to serve on ...

Q4 2023 Fulcrum Therapeutics Inc Earnings Call

20d ago, source: Yahoo Finance

Matthew Biegler; Analyst; Oppenheimer & Co., Inc. Andrea Park; Analyst; Leerink Partners Dae Gon Ha; Analyst; Stifel Operator Good morning and welcome to Fulcrum Therapeutics Fourth Quarter and ...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023

21d ago, source: Business Insider

Feb. 27, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the ...

Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer

19h ago, source:

Industry veteran with late-stage clinical development, medical affairs, and regulatory experience; well-positioned to advance losmapimod towards ...

Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer

19h ago, source: Finanznachrichten

?Industry veteran with late-stage clinical development, medical affairs, and regulatory experience; well-positioned to advance losmapimod towards a potential regulatory submission and approval ? ?

Fulcrum Therapeutics, Inc. (FULC) Q4 2023 Earnings Call Transcript

20d ago, source: Seeking Alpha

Good morning and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call. Currently all participants are in listen-only mode.

Fulcrum Therapeutics Inc FULC

11d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript

19d ago, source: Insider Monkey

Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44. FULC isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...